References
- Members WG, Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38.
- Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13:178–194.
- Adams RJ, Albers G, Albers MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Chin J Cerebrovasc Dis. 2008;39:1647–1652.
- Campbell CL, Smyth S, Montalescot G, et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA. 2007;297:2018–2024.
- Okada K, Inamori M, Imajo K, et al. Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients. Hepatogastroenterology. 2009;56:1665–1669.
- Kierys A. Synthesis of aspirin-loaded polymer-silica composites and their release characteristics. ACS Appl Mater Interfaces. 2014;6:14369.
- Aabakken L, Bjørnbeth BA, Hofstad B, et al. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules. Scand J Gastroenterol. 1989;163:65.
- Mašić I, Ilić I, Dreu R, et al. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation. Int J Pharm. 2012;423:202–212.
- Cebe P, Chung SY, Hong SD. Effect of thermal history on mechanical properties of polyetheretherketone below the glass transition temperature. J Appl Polym Sci. 1987; \33:487–503.
- Sato Y, Inagaki Y, Tajima H, et al, inventors. Powder coating. EP0845507. 2003.
- Pai R, Pai A, Srivastava B, et al. Development and in vitro evaluation of ketoprofen extended release pellets using powder layering technique in a rotary centrifugal granulator. CCHTS. 2011;14:138–145.
- Sahu PK, Rao RN, Cecchi T, et al. An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal. 2018;147:590–611.
- Anand O, Yu LX, Conner DP, et al. Dissolution testing for generic drugs: an FDA perspective. AAPS J. 2011;13:328.
- Sorensen LS, Schwartz AP, Sondergaard-Andersen J, inventors. Method for dissolution testing of pharmaceutical products. WO, EP 1966611 B1. 2012.
- Muralidharan S, Kalaimani J, Parasuraman S, et al. Development and validation of acyclovir HPLC external standard method in human plasma: application to pharmacokinetic studies. Adv Pharm. 2014;2014:1.
- Liao Z, Liang X, Jiang Q, et al. The release mechanism and efficacy evaluation of Guizhi Fuling skeletal sustained-release double layer tablets. Pharmacol Clin Chin Mater Med. 2010.
- Pan J, Lu W, Li C, et al. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies. Arch Pharm Res. 2010;33:1209–1216.
- Karmarkar AB, Gonjari ID, Hosmani AH, et al. Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. Drug Discov Ther. 2010;4:26.
- Zhang X, Yi Y, Qi J, et al. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs. Int J Pharm. 2013;452:233.
- Sahebi S, Phuntsho S, Kim JE, et al. Pressure assisted fertiliser drawn osmosis process to enhance final dilution of the fertiliser draw solution beyond osmotic equilibrium. J Membr Sci. 2015;481:63–72.
- Shaw J, inventor. Controlled release delivery system of solid dosage form. US 6770297 B1. 2004.
- Mukai K. Membrane structure, process for making membrane structure, and aqueous dispersion for forming membrane structure. 2012.
- Schroeder WF, Liu Y, Tomba JP, et al. Effect of a coalescing aid on the earliest stages of polymer diffusion in poly(butyl acrylate-co-methyl methacrylate) latex films. Polymer. 2011;52:3984–3993.
- Clough A, Peng D, Yang Z, et al. Glass transition temperature of polymer films that slip. Macromolecules. 2011;44:1649–1653.